Author | Christopher Sweeney, MBBS | OncLive

Author | Christopher Sweeney, MBBS

Articles

Dr. Sweeney on the Phase III ENZAMET Trial in Metastatic Hormone-Sensitive Prostate Cancer

June 03, 2019

Video

Christopher Sweeney, MBBS, medical oncologist at the Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, discusses results of the phase III ENZAMET trial, which looked at standard therapy with or without enzalutamide as a treatment for patients with metastatic hormone-sensitive prostate cancer.

Dr. Sweeney on Chemotherapy in Prostate Cancer

January 19, 2018

Video

Christopher Sweeney, MBBS, medical oncologist, Dana-Farber Cancer Institute, discusses when to give docetaxel as a treatment option for patients with prostate cancer.

Dr. Sweeney Discusses Tailoring Treatment in Prostate Cancer

January 11, 2018

Video

Christopher Sweeney, MBBS, medical oncologist, Dana-Farber Cancer Institute, discusses tailoring treatment to individual patients with prostate cancer.

Dr. Sweeney on Chemotherapy Versus Abiraterone for mCRPC

December 14, 2017

Video

Christopher Sweeney, MBBS, medical oncologist, Dana-Farber Cancer Institute, discusses the role of chemotherapy versus abiraterone (Zytiga) for patients with metastatic castration-resistant prostate cancer (mCRPC).

x